Dysbetalipoproteinemia (DBL)
1 clinical trials · Condition
◉ Watch Dysbetalipoproteinemia (DBL)
| Record | Firm | Date |
|---|---|---|
| Compassionate Use of Evinacumab (NCT06500598) | Regeneron Pharmaceuticals |
Track Dysbetalipoproteinemia (DBL) automatically
Every clearance here is in the API, with alerts when new ones post.